secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001104659-23-006536
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics dismisses BDO, engages KPMG as new auditor
--------------------------------------------------------------

- BDO dismissed as independent auditor effective Jan 21, 2023; prior reports had going concern explanatory paragraph.
- No disagreements or reportable events during fiscal years 2021 and 2020 and subsequent interim periods.
- KPMG engaged as new independent auditor for fiscal year ending Dec 31, 2022, effective Jan 23, 2023.
- No prior consultations with KPMG on accounting principles, disagreements, or reportable events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923006536/0001104659-23-006536-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923006536/tm234276d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-006536

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer